Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Open Multicentre, Phase IV Study to Evaluate Efficacy and Safety of Pegylated Interferon Alpha-2a (40 KD) Plus Ribavirin for Chronic Hepatitis C With Normal Transaminases in Human Immunodeficiency Virus-infected Patients

NCT01684787 is registered in ClinicalTrials.gov with Miguel Santin as lead sponsor.

NCT NCT01684787
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01684787 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Open Multicentre, Phase IV Study to Evaluate Efficacy and Safety of Pegylated Interferon Alpha-2a (40 KD) Plus Ribavirin for Chronic Hepatitis C With Normal Transaminases in Human Immunodeficiency Virus-infected Patients
Lead sponsor
Miguel Santin
Phase
Phase 4
Overall status
Completed
Start date
September 30, 2006
Completion date
June 30, 2011
Enrollment
80 (actual)
Sites
18

Conditions

As the registry lists them; a condition with its own page is linked.

chronic hepatitis c